The Hidden Costs of In Vivo Research: Avoiding Budget Pitfalls to Maximize Study Success Date

Moving into the in vivo stage of drug development means decision have greater impact and risk. Whether ensuring animal health and genetics or securing vivarium lab space, the choices you make now can have a major impact on your timeline and budget. Yet, many early-stage teams are unaware of the hidden costs that can derail progress and strain resources.

Join our webinar to uncover the hidden costs and discover practical strategies to avoid them. You’ll learn how to plan smarter, align your resources with therapeutic goals, and set your program up for success before your study begins. Whether you’re an academic researcher, a biotech team leader, or an early-stage drug developer, this session is designed to help you make informed decisions that keep your research on track while saving time and money.

You’ll learn:

• How to identify and avoid common budget pitfalls in the preclinical in vivo stage
• Best practices for selecting animal models that align with your therapeutic objectives
• Why engaging model experts early and planning for animal health and genetics can prevent costly delays
• Key questions to ask during vendor evaluations to ensure operational support and facility readiness